PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $444,000 | +31.4% | 7,267 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $338,000 | -7.9% | 7,226 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $367,000 | +14.0% | 7,226 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $322,000 | -4.5% | 7,226 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $337,000 | +42.2% | 7,016 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $237,000 | -25.0% | 7,016 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $316,000 | -14.6% | 7,016 | -28.7% | 0.00% | 0.0% |
| Q1 2019 | $370,000 | +12.8% | 9,834 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $328,000 | -23.9% | 9,558 | +4.1% | 0.00% | 0.0% |
| Q3 2018 | $431,000 | +81.1% | 9,178 | +30.0% | 0.00% | +100.0% |
| Q2 2018 | $238,000 | +53.5% | 7,060 | -55.3% | 0.00% | 0.0% |
| Q1 2017 | $155,000 | -11.4% | 15,783 | -1.4% | 0.00% | -50.0% |
| Q4 2016 | $175,000 | -2.8% | 16,001 | +24.8% | 0.00% | 0.0% |
| Q3 2016 | $180,000 | +100.0% | 12,817 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $90,000 | – | 12,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $294,255,421 | 5.60% |
| Camber Capital Management LP | 2,500,000 | $101,675 | 3.31% |
| COWEN AND COMPANY, LLC | 799,511 | $32,516,112 | 2.70% |
| ARMISTICE CAPITAL, LLC | 3,236,000 | $131,608,120 | 1.90% |
| SECTORAL ASSET MANAGEMENT INC | 231,696 | $9,423,076 | 1.57% |
| GEORGE KAISER FAMILY FOUNDATION | 53,572 | $7,623,296 | 1.29% |
| Redwood Investments, LLC | 245,578 | $9,987,657 | 1.22% |
| Integral Health Asset Management, LLC | 174,000 | $7,076,580 | 0.88% |
| Sofinnova Investments, Inc. | 260,443 | $10,592,217 | 0.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,100 | $4,071,067 | 0.64% |